The report "Process Analytical Technology Market by Modality (Spectroscopy: Raman, IR; Chromatography: HPLC, GC; MS), Product (Analyzer, Probe, Sensor, Software), Measurement (Online, Inline, At-line), Application (Mfg QA/QC, Drug Discovery) - Global Forecast to 2031", The global process analytical technology (PAT) market is projected to reach USD 11.49 billion by 2031 from USD 5.79 billion in 2026, at a CAGR of 14.7% during the forecast period. Growing research spending by biopharmaceutical companies, stringent regulatory requirements for drug safety, improvements in drug quality, and technological advancements are key factors fueling the adoption of PAT technologies globally.
Browse 218 market data Tables and 56 Figures spread through 285 Pages and in-depth TOC on "Process Analytical Technology Market by Modality (Spectroscopy: Raman, IR; Chromatography: HPLC, GC; MS), Product (Analyzer, Probe, Sensor, Software), Measurement (Online, Inline, At-line), Application (Mfg QA/QC, Drug Discovery) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/process-analytical-technology-market-59564006.html
Molecular spectroscopy to register significant growth over the forecast period of 2026-2031
Based on technology, the global PAT market has been classified into five major segments: spectroscopy, chromatography, particle size analysis, capillary electrophoresis, and other technologies. The molecular spectroscopy segment is projected to witness significant growth during the forecast period due to its extensive applications in pharmaceutical analysis, protein characterization, pathogen detection, and bioprocess monitoring. The increasing complexity of biologics and advanced therapeutics is driving demand for highly sensitive analytical tools capable of delivering rapid and accurate results. Furthermore, growing investments in biopharmaceutical R&D, implementation of continuous manufacturing practices, and advances in Raman and NIR spectroscopy technologies are accelerating segment growth. The emergence of real-time release testing (RTRT) and AI-driven data analytics is further strengthening the adoption of molecular spectroscopy across pharmaceutical manufacturing facilities.
On-line measurement dominated the market in terms of measurement in 2025
The on-line segment accounted for the largest market share in 2025, owing to its ability to provide continuous, real-time monitoring of critical process parameters during pharmaceutical manufacturing. Compared with at-line and off-line methods, on-line analysis offers faster decision-making, reduced turnaround times, improved process consistency, and enhanced product quality. The increasing shift toward continuous manufacturing, automated process control systems, and real-time release testing is accelerating the adoption of on-line PAT solutions. Emerging trends such as cloud-based process monitoring, digital twins, and AI-enabled predictive analytics are further expanding the use of on-line measurement technologies across pharmaceutical and biopharmaceutical production facilities.
The North America market is expected to hold a major share in the market during the forecast period.
North America held the largest share of the process analytical technology (PAT) market in 2025 due to its strong pharmaceutical and biotechnology industry, high R&D investments, and early adoption of advanced manufacturing technologies. Stringent regulatory requirements, increasing implementation of Quality by Design (QbD) and continuous manufacturing, and growing adoption of AI-driven process analytics further support market growth in the region.
As of 2025, prominent players in the PAT market are Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Waters Corporation (US), Bruker Corporation (US), Emerson Electric Co. (US), ABB Ltd. (Switzerland), PerkinElmer, Inc. (US), Mettler-Toledo International Inc. (US), and Carl Zeiss AG (Germany), among others.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com